Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
UOC ISP Prevention of Infectious and Chronic Diseases, Department of Prevention, Area Vasta 2 Fabriano, Regional Health Authority, Marche Region, Italy.
J Clin Virol. 2021 Apr;137:104763. doi: 10.1016/j.jcv.2021.104763. Epub 2021 Feb 27.
Enterovirus infections can cause a variety of illnesses, ranging from asymptomatic infections to severe illness and death.
To support polio eradication activities, in February 2019, the WHO Regional Reference Laboratory for polio in Italy, at the National Institute of Public Health (Istituto Superiore di Sanità), promoted an investigation on non-polio enterovirus laboratory capacity, with the support of the Italian Ministry of Health. The aim was to collect data on the assays used routinely for diagnostic purposes and to characterize enterovirus outbreaks strains by sequence analysis of the Viral Protein 1 region.
A questionnaire was administered to public health laboratories through all Italian Regions for 2018 and subsequently, an electronic form for lab-confirmed enterovirus infection reported from February 2019 to January 2020, including patients clinical characteristics, and laboratory data was distributed through 25 laboratories participating the survey.
Overall, a homogenous laboratory capacity for enterovirus infection diagnosis was found and 21,000 diagnostic tests were retrospectively reported in 2018. Then, in 2019, two outbreaks of Echovirus 30 were identified and confirmed by molecular analyses.
These results underline the need monitor the circulation of non-polio enterovirus to ascertain the real burden of the disease in the country.
肠道病毒感染可引起多种疾病,从无症状感染到严重疾病甚至死亡。
为支持脊髓灰质炎根除活动,2019 年 2 月,意大利国家公共卫生研究所(Istituto Superiore di Sanità)的世卫组织脊髓灰质炎区域参考实验室在意大利卫生部的支持下,对非脊髓灰质炎肠道病毒实验室能力进行了调查。目的是收集用于诊断目的的常规检测方法的数据,并通过对病毒蛋白 1 区进行序列分析来对肠道病毒暴发株进行特征描述。
通过意大利所有地区的公共卫生实验室发放问卷,并随后分发了一份电子表格,用于报告 2019 年 2 月至 2020 年 1 月期间实验室确诊的肠道病毒感染病例,包括患者的临床特征和实验室数据,共有 25 个参与调查的实验室参与了报告。
总体而言,发现了一种同质化的肠道病毒感染诊断实验室能力,2018 年共报告了 21,000 次诊断检测。随后,在 2019 年,通过分子分析鉴定并确认了两起埃可病毒 30 型暴发疫情。
这些结果强调了需要监测非脊髓灰质炎肠道病毒的流行情况,以确定该疾病在该国的实际负担。